Diseases of skin and subcutaneouse tissue. L00-L99
Conditions
Interventions
Intervention 1: Intervention group1: Samples(n=37) will receive per-filled syringe of enoxaparin sodium 6000 IU (prepared by Alborzdarou company), subcutaneously after administration on the right of
Sponsors
Research and Technology Deputy of Guilan University of Medical Sciences.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: requiring hospital admission for at least 72 hours after receiving the second injection in the left abdomen treatment with Enoxaparin sodium with a dose of 6000 units having the results of the latest coagulation tests include INR, PTT, PT in the range of therapy (up to 1.5-2.5 as normal), normal amounts of platelets and hematocrit adequate renal function (creatinine 1.5-0.5 mg / dL) lack of extensive skin lesions on the abdomen such as extensive scarring due to surgery or burn lack of conditions preventing the correct implementation of the Enoxaparin injection method such as sever Ascites abdominal bruises from the previous injection satisfaction to participate in the research by signing a written consent
Exclusion criteria
Exclusion criteria: event of any change in the clinical condition is required changing in the amount or discontinuation of the drug performing subcutaneous injections Enoxaparin sodium on the right side of the abdomen by personnel unwillingness to continue cooperation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The extent of bruising in area of Enoxaparin sodium in Milimeter. Timepoint: 24,48 and 72 hours after intervention. Method of measurement: Recording the bruising extent based on multiplication of the largest diameter in the smallest diameter (by flexible ruler in millimeter) in prepared form.;The incidence of bruising in site of Enoxaparin sodium injection:discoloration in skin to violet color at least 2 mm. Timepoint: 24,48 and 72 hours after intervention. Method of measurement: Recording the observed bruising in prepared form by flexible ruler in millimeter)to measure skin discoloration. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAtaollah asadi louyeh
Guilan university of medical sciences,Beheshti nursing and midwifery college
Outcome results
None listed